
Lifestance Health Group ( ($LFST) ) has shared an update. On November 9, 2026, LifeStance Health Group entered into an underwriting agreement for an offering of 45 million common shares
Compare up to 40 stocks
Compared Stocks: 2 / 40
| Name | Price | % Change | |
|---|---|---|---|
| $13.82 | +114.60% | ||
| $34.60 | +127.93% |

Lifestance Health Group ( ($LFST) ) has shared an update. On November 9, 2026, LifeStance Health Group entered into an underwriting agreement for an offering of 45 million common shares

JPMorgan analyst Lisa Gill raised the firm’s price target on LifeStance (LFST) to $15 from $13 and keeps a Neutral rating on the shares. The firm updated the company’s estimates.

Barclays raised the firm’s price target on LifeStance (LFST) to $18 from $15 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for

Deutsche Bank raised the firm’s price target on Acadia Healthcare (ACHC) to $46 from $32 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate

Barclays and JPMorgan acted as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’

This filing relates to the offer and sale from time to time by the selling stockholders of up to 45M shares of common stock. The company is not selling any

RBC Capital raised the firm’s price target on Acadia Healthcare (ACHC) to $41 from $31 and keeps an Outperform rating on the shares. The firm is positive on the company’s

UBS analyst AJ Rice raised the firm’s price target on Acadia Healthcare (ACHC) to $45 from $41 and keeps a Buy rating on the shares. Published first on TheFly –

Analyst David Larsen from BTIG maintained a Buy rating on Lifestance Health Group and increased the price target to $20.00 from $18.00. David Larsen’s rating is based on Lifestance Health’s

Cantor Fitzgerald analyst Sarah James raised the firm’s price target on Acadia Healthcare (ACHC) to $39 from $30 and keeps a Neutral rating on the shares. Acadia Healthcare delivered a
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Nov 15, 2026 | ||||
| hold | Reiterated | Nov 12, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Assigned | Nov 9, 2026 | ||||
| buy | Reiterated | Nov 9, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.